Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Links between Toll-like receptor 4 and breast cancer.

Ahmed A, Redmond HP, Wang JH.

Oncoimmunology. 2013 Feb 1;2(2):e22945.

2.

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.

González-Reyes S, Marín L, González L, González LO, del Casar JM, Lamelas ML, González-Quintana JM, Vizoso FJ.

BMC Cancer. 2010 Dec 3;10:665. doi: 10.1186/1471-2407-10-665.

3.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
4.

Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.

Netea MG, van der Graaf C, Van der Meer JW, Kullberg BJ.

J Leukoc Biol. 2004 May;75(5):749-55. Epub 2004 Jan 14. Review.

5.

Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.

Yang H, Zhou H, Feng P, Zhou X, Wen H, Xie X, Shen H, Zhu X.

J Exp Clin Cancer Res. 2010 Jul 10;29:92. doi: 10.1186/1756-9966-29-92.

6.

Regulation of innate immune responses by Toll-like receptors.

Takeda K, Akira S.

Jpn J Infect Dis. 2001 Dec;54(6):209-19. Review.

PMID:
11862002
7.

Microbial recognition by Toll-like receptors.

Takeda K, Akira S.

J Dermatol Sci. 2004 Apr;34(2):73-82. Review.

PMID:
15033189
8.
9.

Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.

Basith S, Manavalan B, Yoo TH, Kim SG, Choi S.

Arch Pharm Res. 2012 Aug;35(8):1297-316. doi: 10.1007/s12272-012-0802-7. Epub 2012 Sep 1. Review.

PMID:
22941474
10.

Regulation of dendritic cell function through Toll-like receptors.

Kaisho T, Akira S.

Curr Mol Med. 2003 Jun;3(4):373-85. Review.

PMID:
12776992
11.

Dual character of Toll-like receptor signaling: pro-tumorigenic effects and anti-tumor functions.

Yu L, Wang L, Chen S.

Biochim Biophys Acta. 2013 Apr;1835(2):144-54. doi: 10.1016/j.bbcan.2012.10.006. Epub 2012 Dec 8. Review.

PMID:
23232186
12.

Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.

Ofodile ON.

J Ind Microbiol Biotechnol. 2007 Dec;34(12):751-62. Epub 2007 Sep 5. Review.

PMID:
17876621
13.

Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses.

Kirschning CJ, Bauer S.

Int J Med Microbiol. 2001 Sep;291(4):251-60. Review.

PMID:
11680785
14.

Toll-like receptors on tumor cells facilitate evasion of immune surveillance.

Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, Mayer L, Unkeless JC, Xiong H.

Cancer Res. 2005 Jun 15;65(12):5009-14. Erratum in: Cancer Res. 2005 Oct 1;65(19):9108. Chen, Shu-Hsia [added].

15.

Toll-like receptors as adjuvant receptors.

Kaisho T, Akira S.

Biochim Biophys Acta. 2002 Feb 13;1589(1):1-13. Review.

16.

Toll-like receptors as sensors of pathogens.

Hallman M, Rämet M, Ezekowitz RA.

Pediatr Res. 2001 Sep;50(3):315-21. Review.

PMID:
11518816
17.

Toll-like receptors: cost or benefit for cancer?

Matijevic T, Pavelic J.

Curr Pharm Des. 2010;16(9):1081-90. Review.

PMID:
20030618
18.

Toll-like receptor signaling pathways.

Barton GM, Medzhitov R.

Science. 2003 Jun 6;300(5625):1524-5.

PMID:
12791976
19.

Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment.

Bhattacharya D, Yusuf N.

Int J Breast Cancer. 2012;2012:716564. doi: 10.1155/2012/716564. Epub 2011 Nov 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk